Cedars-Sinai Medical Center invests USD 525.000 in Neolook Solutions – first US institutional investor

Neolook Solutions B.V., the Dutch neonatal digital health company, has secured USD 525.000 from Cedars-Sinai Medical Center (Los Angeles, California) via a Post-Money SAFE at a USD 7,5 million valuation cap. The investment constitutes Neolook Round 3 and makes Cedars-Sinai the first US institutional investor in the company.

The commitment is the direct outcome of a structured three-track international expansion programme executed by Neolook across 2024 and 2025. In the Middle East, Neolook was selected as 1 of 6 startups for the Anjal Z Techstars Founder Catalyst programme (Cohort 05) from 264 global applicants, backed by the Abu Dhabi Early Childhood Authority. In Southeast Asia, Neolook activated a market entry track via Invest International, the Dutch government's internationalisation instrument. In the United States, the ScaleNL programme created the institutional pipeline that led directly to the Cedars-Sinai relationship.

The investment is structured as a Post-Money SAFE with a 20 % discount and includes a linked Milestone Equity Agreement. The milestone equity component grants Cedars-Sinai additional rights conditional on three deliverables: a clinical trial, a health economic study and a demonstrated FDA readiness pathway. Cedars-Sinai becomes Neolook's first US reference site and a co-development partner on the clinical and regulatory evidence required for US market entry.